How to run an effective and efficient dermato-oncology unit: A Dutch approach;Wie kann eine Abteilung für Dermato-Onkologie effektiv und effizient betrieben werden: ein niederländischer Ansatz

JDDG - Journal of the German Society of Dermatology

Volumn 8, Issue 1, 2010, Pages 15-19

  Geer, Simone Van Der ^a   Reijers, Hajo ^b   Krekels, Gertruud ^c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

^c Catharina Krankenhaus Eindhoven   (Netherlands)

Author keywords

Dermato oncology; Management; Skin cancer

Indexed keywords

BASAL CELL NEVUS SYNDROME; DERMATOLOGY; GENERAL PRACTITIONER; HEALTH CARE; HEALTH CARE MANAGEMENT; HEALTH CARE PERSONNEL; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HOSPITAL; HOSPITAL ADMISSION; HUMAN; INFORMATION TECHNOLOGY; PREVALENCE; REVIEW; SKIN CANCER;

DELIVERY OF HEALTH CARE; DERMATOLOGY; HUMANS; LEADERSHIP; MEDICAL ONCOLOGY; MODELS, ORGANIZATIONAL; NETHERLANDS; SKIN NEOPLASMS;

EID: 74849116688     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2009.07121.x     Document Type: Review

References (32)

1. Rigel DS, Friedman RJ, Kopf AW. Lifetime risk for development of skin cancer in the U.S. population: Current estimate is now 1 in 5. J Am Acad Dermatol 1996 35: 1012 1013.
2. Vries de E, Rhee Van Der H, Coebergh JWW. Trends, oorzaken, aanpak en gevolgen van de huidkankerepidemie in Nederland en Europa. Ned Tijdschr Geneeskd 2006 150: 1108 1115.
3. Vries de E, Poll-Franse van de LV, Louwman WJ, Gruijl de FR, Coebergh JWW. Predictions of skin cancer incidence in the Netherlands up to 2015. Br J Dermatol 2005 152: 481 488.
4. Dutch transplant society (Nederlandse transplantatie stichting). http://www.transplantatiestichting.nl/cms/mediaobject.php?file=nts-2008-januari. pdf.
5. Moloney FJ, Comber H, O'Lorcain P, O'Kelly P, Conlon PJ, Murphy GM. A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br J Dermatol 2006 154: 498 504.
6. Carroll RP, Ramsay HM, Fryer AA, Path FMRC, Hawley CM, Nicol DL, Harden PNl. Incidence and prediction of nonmelanoma skin cancer post-renal transplantation: a prospective study in Queensland, Australia. Am J Kidney Dis 2003 41: 676 683.
7. Marcil I, Stern RS. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer. Arch Dermatol 2000 136: 1524 1530.
8. Collins GL, Nickoonahand N, Morgan MB. Changing demographics and pathology of nonmelanoma skin cancer in the last 30 years. Semin Cutan Med Surg 2004 23: 80 3.
9. Karagas MR, Greenberg ER, Spencer SK, Stukel TA, Mott LA. Increase in incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA. Int J Cancer 1999 81: 555 559.
10. Ramchandran S, Fryer AA, Smith A, Lear J, Bowers B, Jones PW, Strange RC. Cutaneous basal cell carcinomas. Distinct host factors are associated with the development of tumors on the trunk and on the head an neck. Cancer 2001 92: 354 358.
11. Wagener DL. Dermatology practice management assures practice development and efficiency. Sem Cutan Med Surg 2000 19: 170 172.
12. Baker KE. Will a physician assistant improve your dermatology practice? Sem Cutan Med Surg 2000 19: 201 203.
13. Nestor MS. Dermatology practice management enhancement: implications for dermatology in the age of managed care. Sem Cutan Med Surg 2000 19: 163 169.
14. Christenson LJ, Geusau A, Ferrandiz C, Brown CD, Ulrich C, Stockfletch E, Berg D, Orengo I, Shaw JC, Carucci JA, Euvrard S, Pachego T, Stasko T, Otley CC. Specialty clinics for the dermatologic care of solid organ transplant recipients. Dermatol Surg 2004 30: 598 603.
15. Ismail F, Mitchell L, Casabonne D, Gulati A, Newton R, Proby CM, Harwood CA. Specialist dermatology clinics for organ transplant recipients significantly improve compliance with photoprotection and levels of skin cancer awareness. Br J Dermatol 2006 155: 916 925.
16. Housman TS, Feldman SR, Williford PM, Fleischer AB, Goldman ND, Acostamadiedo JM, Chen GJ. Skin cancer is among the most costly of all cancers to treat for the Medicare population. J Am Acad Dermatol 2003 48: 425 429.
17. Smeets NW, Krekels GA, Ostertag JU, Essers BA, Dirksen CD, Nieman FH, Neumann HA. Lancet 2004 364: 1766 1772.
18. Moreno-Ramirez D, Ferrandiz L, Nieto-Garcia A, Carrasco R, Moreno-Alvarez P, Galdeano R, Bidegain E, Rios-Martin JJ, Camacho FM. Store-and-forward teledermatology in skin cancer triage. Arch Dermatol 2007 143: 479 484.
19. May C, Giles L, Gupta G. Prospective observational comparative study assessing the role of store and forward tele-dermatology triage in skin cancer. Clin Exp Dermatol 2008 33: 736 739.
20. Barr Taylor C, Houston Miller N, Reilly KR, Greenwald G, Cunning D, Deeter A, Abascal L. Evaluation of a nurse-care management system to improve outcomes in patients with complicated diabetes. Diabetes Care 2003 26: 1058 1063.
21. Courtenay M, Carey N. A review of the impact and effectiveness of nurse-led care in dermatology. J Clin Nurs 2007 16: 122 128.
22. Fieschi M, Dufour JC, Staccini P, Gouvernet J, Bouhaddou O. Medical decision support systems: old dilemmas and new paradigms? Methods Inf Med 2003 3: 190 198.
23. Maviglia SM, Zielstorff RD, Paterno M, Teich JM, Bates DW, Kuperman GJ. Automating complex guidelines for chronic disease: lessons learned. J Am Med Inform Assoc 2003 10: 154 165.
24. Lenz R, Reichert M. IT Support for healthcare processes premises, challenges, perspectives. Data Knowledge Engineering 2007 61: 39 58.
25. Kuijpers DI, Smeets NW, Krekels GA, Thissen MR. Photodynamic therapy as adjuvant treatment of extensive basal cell carcinoma treated with Mohs micrographic surgery. Dermatol Surg 2004 30: 794 798.
26. Thissen MR, Kuijpers DI, Krekels GA. Local immune modulator (imiquimod 5% cream) as adjuvant treatment after incomplete Mohs micrographic surgery for large, mixed type basal cell carcinoma: a report of 3 cases. J Drugs Dermatol 2006 5: 461 464.
27. Tsjui T, Otake N, Nishimura M. Cryosurgery and topical fluorouracil: a treatment method for widespread basal cell epithelioma in basal cell nevus syndrome. J Dermatol 1993 20: 507 513.
28. Strange PR, Lang PG. Long-term management of basal cell nevus syndrome with topical tretinoin and 5-fluorouracil. J Am Acad Dermatol 1992 27: 842 845.
29. Krunic AL, Viehman GE, Madani S, Clark RE. Microscopically controlled surgical excision combined with ultra-pulse CO2 vaporization in the management of a patient with the nevoid basal cell carcinoma syndrome. J Dermatol 1998 25: 10 2.
30. Geer Van Der S, Ostertag JU, Krekels GAM. Treatment of basal cell carcinomas in patients with nevoid basal cell carcinoma syndrome. J Eur Acad Dermatol 2009 23: 308 313.
31. Geer Van Der S, Krekels GAM, Verhaegh ME. Treatment of the Nevoid Basal Cell Carcinoma Syndrome patient in a megasession. A case series. Dermatol Surg 2009. Article in press.
32. Mosterd K, Krekels GA, Nieman FH, Ostertag JU, Essers BA, Dirksen CD, Steijlen PM, Vermeulen A, Neumann HAM, Kelleners-Smeets NWJ. Surgical excision versus Mohs micrographic surgery for primary and recurrent basal cell carcinoma of the face; a prospective randomised controlled trial with 5-years' follow-up. Lancet Oncol 2008 9: 1149 1156.